Tejero Sergio, Prada-Chamorro Estefanía, González-Martín David, García-Guirao Antonio, Galhoum Ahmed, Valderrabano Victor, Herrera-Pérez Mario
Foot and Ankle Unit, Orthopedic Surgery and Traumatology Service, Hospital Universitario Virgen del Rocío, Av. Manuel Siurot, s/n, 41013 Sevilla, Spain.
School of Medicine (Health Sciences), University of Sevilla, Avda Dr. Fedriani, s/n, 41009 Sevilla, Spain.
J Clin Med. 2021 Sep 30;10(19):4561. doi: 10.3390/jcm10194561.
Despite the disabling nature of ankle osteoarthritis (OA), there is poor scientific evidence for a conservative treatment compared to the hip and knee OA. In this regard, most of the treatment options in use are not based on clinical studies of the ankle, and they are extracted from evidence obtained from clinical studies of other lower limb joints. However, this does not seem to be a good idea, since the aetiology of ankle OA is quite different from that of the hip or knee. Nonpharmacological and pharmacological treatments such as nonsteroidal anti-inflammatory drugs, hyaluronic acid, corticosteroid, platelet-rich plasma injection and mesenchymal stem cells injections have been reported. However, further research is required in this field to obtain a specific clinical practice guideline for the conservative treatment of ankle OA.
尽管踝关节骨关节炎(OA)具有致残性,但与髋和膝OA相比,保守治疗的科学证据不足。在这方面,目前使用的大多数治疗方案并非基于踝关节的临床研究,而是从其他下肢关节的临床研究证据中提取的。然而,这似乎并非良策,因为踝关节OA的病因与髋或膝的病因有很大不同。已报道了非甾体抗炎药、透明质酸、皮质类固醇、富血小板血浆注射和间充质干细胞注射等非药物和药物治疗方法。然而,该领域需要进一步研究,以获得踝关节OA保守治疗的具体临床实践指南。